Previous 10 | Next 10 |
-- Latest Variants of Concern, AY.1 and AY.2 Controls Now Available for Development of Accurate Diagnostic Tests -- Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon p...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing first-in-class allogeneic gamma del...
– Research collaboration covers multiple antibody research programs – Twist Bioscience Corporation (NASDAQ:TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a broad-based re...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Jim Thorburn, CFO of Twist Biosc...
The precipitous cost decline of next-generation DNA sequencing has supercharged our understanding of tumor biology. The strange biology that makes it dangerous also gives scientists the opportunity to detect cancer earlier. The exponential cost declines associated with NGS, AI, an...
BOULDER, Colo. & SOUTH SAN FRANCISCO, Calif., Aug. 18, 2021 (GLOBE NEWSWIRE) -- CM Life Sciences II (Nasdaq: CMIIU) and SomaLogic, Inc., a leader in AI-data driven proteomics technology, and Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Jim Thorburn, CFO of Twist Bioscience, and Patrick Finn, chief commercial officer, will host a firesid...
The following slide deck was published by Twist Bioscience Corporation in conjunction with their 2021 Q3 earnings call. For further details see: Twist Bioscience Corporation 2021 Q3 - Results - Earnings Call Presentation
Image source: The Motley Fool. Twist Bioscience Corporation (NASDAQ: TWST) Q3 2021 Earnings Call Aug 6, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: Twist Bioscience Corporation (TWST) Q3 2021 Earnings Call Trans...
Twist Bioscience Corp. (TWST) Q3 2021 Earnings Conference Call August 6, 2021, 8:00 AM ET Company Participants Emily Leproust – CEO and Co-Founder Angela Bitting – SVP of Corporate Affairs Jim Thorburn – CFO Conference Call Participants Doug Schenkel – Cowen Matt S...
News, Short Squeeze, Breakout and More Instantly...
Twist Bioscience Corporation Company Name:
TWST Stock Symbol:
NASDAQ Market:
Twist Bioscience Corporation Website:
Pure Biologics’ exploratory Phase 0 study to evaluate pharmacodynamic activity of PBA-0405 in solid tumors Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today a...
Company to host conference call at 8:00 AM ET Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2024 th...
Express Genes enable faster turnaround times Twist Express Antibodies, CHO starting at 13 business days Twist Express Antibodies, HEK293 starting at 10 business days Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of ...